AdaptHealth Corp. - Class A Common Stock (AHCO)

Historical Holders from Q3 2019 to Q3 2025

Symbol: AHCO on Nasdaq
Type / Class: Equity / Class A Common Stock
Shares outstanding: 281,411,380
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 136,878,731
Holdings value: $1,225,455,719
% of all portfolios: 0%
Number of holders: 224
Number of buys: 109
Number of sells: -100
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of AdaptHealth Corp. - Class A Common Stock (AHCO)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Flynn James E	8.48%		$213,579,981		23,863,685		Deerfield Management Company, L.P.	30 Sep 2025
BlackRock, Inc.	10.9%		$138,311,517		14,667,181		BlackRock, Inc.	30 Jun 2025
VANGUARD GROUP INC	8.33%		$100,933,562		11,277,493		The Vanguard Group	30 Sep 2025
FMR LLC	6.7%	+34%	$84,678,316	+$21,380,950	8,979,673	+34%	FMR LLC	30 Jun 2025
REINHART PARTNERS, LLC.	5.4%		$58,107,184		7,236,262		REINHART PARTNERS, LLC.	31 Mar 2025
Jefferies Financial Group Inc.	3.8%		$40,943,003		5,098,755		JEFFERIES LLC	31 Dec 2024

Institutional Holders of AdaptHealth Corp. - Class A Common Stock (AHCO)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	136,878,731	$1,225,455,719	-$3,002,250	$51,336,581	$14,159,515	$8.95	224
2025 Q2	136,902,285	$1,291,003,973	+$41,802,452	$63,472,510	$14,862,552	$9.43	217
2025 Q1	132,979,873	$1,440,668,696	+$29,808,332	$90,650,256	$39,991,664	$10.84	227
2024 Q4	131,085,924	$1,247,980,281	+$63,505,202	$57,353,368	$54,889,624	$9.52	199
2024 Q3	123,603,441	$1,387,937,026	+$60,196,600	$52,820,028	$122,953,520	$11.23	214
2024 Q2	116,370,859	$1,163,718,130	+$20,268,205	$6,646,000	$16,963,000	$10	206
2024 Q1	113,696,291	$1,308,575,762	+$15,365,696	$612,332	$15,081,553	$11.51	207
2023 Q4	112,806,581	$822,358,955	-$17,053,263	$419,904	$2,415,177	$7.29	191
2023 Q3	113,583,975	$1,033,596,200	+$36,166,490	$3,825,640	$14,256,970	$9.1	189
2023 Q2	108,310,074	$1,318,125,081	-$41,668,212	$2,048,211	$9,255,285	$12.17	180
2023 Q1	111,175,611	$1,381,908,955	+$54,942,279	$2,900,804	$11,958,903	$12.43	165
2022 Q4	106,254,447	$2,043,346,452	+$63,548,944	$10,575,078	$20,984,210	$19.22	189
2022 Q3	102,994,087	$1,935,791,587	+$183,726,139	$9,984,000	$25,710,000	$18.78	174
2022 Q2	93,188,698	$1,682,829,245	-$26,346,076	$9,485,000	$21,127,000	$18.04	143
2022 Q1	94,982,413	$1,523,114,678	+$59,280,029	$774,000	$2,661,000	$16.03	147
2021 Q4	88,175,376	$2,152,259,321	+$198,094,488	$2,067,000	$2,571,000	$24.46	147
2021 Q3	72,216,867	$1,681,937,067	+$71,699,377	$1,817,000	$2,110,000	$23.29	139
2021 Q2	68,685,890	$1,882,685,970	+$16,815,759	$2,206,000	$2,332,000	$27.41	133
2021 Q1	65,167,826	$2,395,786,595	+$789,210,761	$1,163,000	$21,571,540	$36.76	143
2020 Q4	28,862,834	$1,084,347,205	+$256,339,491	$950,000		$37.56	131
2020 Q3	25,503,341	$556,879,976	+$332,958,250		$0	$21.81	79
2020 Q2	10,303,667	$165,891,000	-$226,130,665		$3,217,000	$16.1	52
2020 Q1	24,351,453	$389,621,000	+$30,369,902		$4,000,000	$16	34
2019 Q4	22,596,299	$247,953,000	+$235,213,000		$2,745,000	$10.98	22
2019 Q3	1,249,993	$12,740,000	+$12,740,000			$10.19	2